Article

jdsupra.com on 2020-02-04 00:30

OIG Advisory Opinion Permits a Pharmaceutical Manufacturer to Provide Financial Assistance to Needy Patients Receiving Risky Cell Therapy

The Office of Inspector General for the U.S. Department of Health and Human Services (OIG) recently issued a favorable Advisory Opinion regarding a ...

Related news

OIG Advisory Opinion No. 19-02 Allows Pharmaceutical Manufacturer to Temporarily Loan Smartphones to Financially Needy Patients to Receive Data from a Digestible Medication Sensor jdsupra.com
California , Switzerland , United States
OIG Issues Favorable Advisory Opinion Regarding Free Drug Provided by Pharmaceutical Manufacturer to Patients jdsupra.com
United States
OIG Issues Advisory Opinion Giving the Green Light to a Pharmaceutical Manufacturer’s Plan to Provide Limited Functionality Smartphones to Financially Needy Patients for Adherence Data Monitoring jdsupra.com
California , Switzerland , Spalding , United States
Blog: OIG Provides Strong Rebuke of Pharmaceutical Free Drug Program jdsupra.com
California , United States , Switzerland
Blog: OIG Report on Reasonable Assumptions in Manufacturer Reporting jdsupra.com
California , United States , Switzerland
OIG Issues Favorable Advisory Opinion on Manufacturer-Provided Travel Assistance jdsupra.com
United States
OIG Approves Pharmaceutical Manufacturer’s Loaning of Smartphones to Support Digital Medicine (DM)jdsupra.com
California , United States , Switzerland
OIG Tags Higher Education Grantees Receiving NIH Awards jdsupra.com
United States
OIG Advisory Opinion Allows Smartphone Loan for Needy Patients Taking Digital Drug jdsupra.com
California , United States , Switzerland
OIG Advisory Opinion Has Key Takeaways for Programs Designed to Assist Needy Patients jdsupra.com
California , United States , Switzerland
HHS OIG: Smartphone loaner to needy patients may not violate Anti-Kickback Statute jdsupra.com
California , United States , Switzerland
OIG Releases Report Regarding Reasonable Assumptions in Manufacturer Reporting of Average Manufacturer Prices and Best Prices for Drugs jdsupra.com
California , United States , Switzerland , Spalding
OIG Permits Manufacturer of Personalized Medicine Drug to Cover Patients’ Travel, Lodging, and Other Expenses jdsupra.com
California , United States , Switzerland
OIG Approves Manufacturer Loaning Smartphones as Appropriate Patient Assistance to Support Digital Medicine jdsupra.com
California , United States , Switzerland
OIG Advisory Opinion Allows Pilot Collaborative Program Proposed by Pharmaceutical Manufacturer for Medication Therapy Management Interventions jdsupra.com
OIG Permits Pharmaceutical Manufacturer to Offer Free Drug to Patients in Advisory Opinion 21-01 jdsupra.com
OIG Advisory Opinion Rejects Pharmaceutical Manufacturer’s Proposed Beneficiary Cost-Sharing Program jdsupra.com
Reg , United States
OIG Issues Advisory Opinion Permitting Drug Manufacturer to Provide Travel, Lodging, and Expenses to Patients in Limited Circumstances jdsupra.com
California , United States , Switzerland , Spalding
OIG Anti-Kickback Opinion Examines Physician Ownership of Medical Device Manufacturer and Referrals jdsupra.com
United States
OIG Issues Favorable Advisory Opinion Regarding Pharmaceutical Manufacturer Arrangement to Provide Financial Assistance to Potentially Eligible Patients jdsupra.com